Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance is a research paper published in EBioMedicine (2020). On theSindex it has a DataRank of 0. It has been cited 29 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Carver Trust Young Investigator
Grant: 01-224
NIH
Grant: P30 CA086862
NIH
Grant: F30 CA206255
NIH
Grant: CA200673
NIH
Grant: CA203834
NIGMS NIH HHS
Grant: T32 GM007337
NCI NIH HHS
Grant: R01 CA200673
NCI NIH HHS
Grant: R01 CA203834
National Institutes of Health
Grant: 5F30CA206255-02
The role of paracrine WNT5A/RYK in ErbB2-driven tumorigenesis
National Institutes of Health
Grant: 1R01CA203834-01
CD177 suppresses breast-cancer development by inhibiting beta-catenin
National Institutes of Health
Grant: 1R01CA200673-01
Obesity, inflammation and breast cancer
National Institutes of Health
Grant: 1P30CA086862-01
Core--Clinical trials support group
Carver College of Medicine
Breast Cancer Research
University of Iowa
Carver Trust Young Investigator Award
Department of Anatomy and Cell Biology
Carver Charitable Trust
FWCI
1.14
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals